Search all the public and authenticated articles in CiteULike.
Enter a search phrase. You can also specify

a CiteULike article id (123456),

a DOI (doi:10.1234/12345678)

or a PubMed Id (pmid:12345678).

Click Help for advanced usage.

guhjy's Ruilope:LM [14 articles] Export

Recent papers posted to guhjy's library by the author Ruilope:LM. You can also see everyone's Ruilope:LM.

	Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. [My Copy] Diabetologia (30 October 2009) by E. Ritz, G. C. Viberti, L. M. Ruilope, et al.A. J. Rabelink, J. L. Izzo, S. Katayama, S. Ito, A. Mimran, J. Menne, L. C. Rump, A. Januszewicz, H. Haller posted to uae olmesartan japan by guhjy on 2009-11-08 11:21:45 as
	Should diuretics always be included as initial antihypertensive management in early-stage CKD? [My Copy] Current opinion in nephrology and hypertension, Vol. 18, No. 5. (24 September 2009), pp. 392-396. by Julian Segura, Luis M. Ruilope posted to bp ckd diuretics by guhjy on 2009-07-04 13:43:56 as
	Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. [My Copy] Journal of hypertension, Vol. 27, No. 4. (April 2009), pp. 673-679. by A. Zanchetti, G. Mancia, H. R. Black, et al.S. Oparil, B. Waeber, R. E. Schmieder, G. L. Bakris, F. H. Messerli, S. E. Kjeldsen, L. M. Ruilope posted to bp rct by guhjy on 2009-06-21 02:58:22 as
	Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. [My Copy] J Hypertens, Vol. 24, No. 2. (February 2006), pp. 403-408. by H. Haller, G. C. Viberti, A. Mimran, et al.G. Remuzzi, A. J. Rabelink, E. Ritz, L. C. Rump, L. M. Ruilope, S. Katayama, S. Ito, J. L. Izzo, A. Januszewicz posted to arb cv dn normoalbuminuria olmesartan primary-prevention rct uae by guhjy on 2009-01-21 14:55:03 as
	Clinical trials in nephrology: success or failure. [My Copy] Current opinion in nephrology and hypertension, Vol. 16, No. 2. (March 2007), pp. 59-63. by J. A. Garcia-Donaire, J. Segura, L. M. Ruilope posted to ckd rct by guhjy on 2009-01-21 14:51:03 as
	Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 46, No. 6. (December 2005), pp. 1074-1079. by P. Aranda, J. Segura, L. M. Ruilope, et al.F. J. Aranda, M. A. Frutos, V. López, E. López de Novales posted to renoprotection ndrd rct telmisartan by guhjy on 2009-01-17 05:26:05 as
	Calcium channel blockers and renal protection: insights from the latest clinical trials. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 16 Suppl 1 (March 2005) by J. Segura, J. A. García-Donaire, L. M. Ruilope posted to aask ccb ckd rct by guhjy on 2009-01-01 14:22:41 as
	Occult lead intoxication as a cause of hypertension and renal failure. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 11, No. 9. (September 1996), pp. 1775-1780. by A. I. Sánchez-Fructuoso, A. Torralbo, M. Arroyo, et al.M. Luque, L. M. Ruilope, J. L. Santos, A. Cruceyra, A. Barrientos posted to bp ckd lead by guhjy on 2008-10-17 02:51:45 as
	Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension [My Copy] Kidney Int, Vol. 66, No. S92. (November 2004), pp. S45-S49. by Julian Segura, Carlos Campo, Luis M. Ruilope posted to bp cv gfr proteinuria by guhjy on 2008-10-05 03:47:42 as
	Blood pressure control in patients with comorbidities. [My Copy] Journal of clinical hypertension (Greenwich, Conn.), Vol. 10, No. 8. (August 2008), pp. 624-631. by R. E. Schmieder, L. M. Ruilope posted to bp rx by guhjy on 2008-10-01 17:11:10 as
	Prospects for renovascular protection by more aggressive renin-angiotensin system control. [My Copy] Medscape journal of medicine, Vol. 10 Suppl (2008) by L. M. Ruilope, A. Jakobsen, J. Heroys, A. Ralph, T. Rees, M. Shaw posted to acei arb dose by guhjy on 2008-06-29 05:07:50 as
	Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy? [My Copy] Current opinion in nephrology and hypertension, Vol. 16, No. 5. (September 2007), pp. 422-426. by J. Segura, J. A. García-Donaire, L. M. Ruilope posted to ccb ckd by guhjy on 2008-06-17 04:21:48 as
	Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 17, No. 12 Suppl 3. (December 2006) by P. Gomez, L. M. Ruilope, V. Barrios, et al.J. Navarro, M. A. Prieto, O. Gonzalez, L. Guerrero, M. A. Zamorano, C. Filozof, posted to no-tag by guhjy on 2008-04-13 05:26:30 as
	Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. [My Copy] J Hypertens, Vol. 25, No. 7. (July 2007), pp. 1473-1479. by L. M. Ruilope, A. Zanchetti, S. Julius, et al.G. T. McInnes, J. Segura, P. Stolt, T. A. Hua, M. A. Weber, K. Jamerson, posted to no-tag by guhjy on 2007-12-14 15:16:11 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Ruilope:LM

guhjy's tags

All tags in guhjy's library

Filter:

Only showing top 500 tags from 2925 total.

CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.

ckd	1740
rct	1201
dn	1078
dm	1001
cancer	994
ma	970
cv	912
hd	860
tgfb	793
snp	760
bp	640
ros	571
meta-analysis	515
uae	499
stats	479
kidney	478
software	462
mouse	455
genetics	447
mirna	444
pt	417
proteomics	410
mortality	408
inflammation	364
fbl	359
rat	356
proteinuria	355
pcr	348
tw	345
gdl	331
acei	331
db	326
test	325
inhibitor	319
urine	315
arb	314
method	311
ms	310
apoptosis	302
hcv	300
mc	300
age	298
r	292
aging	289
biomarker	286
irs	282
akt	278
bias	277
ppi	277
bayes	275
mtor	270
aki	269
gwa	268
aii	261
hg	258
nutrition	255
rnai	242
emt	242
ub	239
p53	235
fibrosis	232
egfr	231
cox	226
obesity	223
smad	222
pbmc	220
pi3k	216
metab	213
drug	213
hcc	210
gn	208
1	205
hypoxia	204
herb	199
erk	191
albumin	189
lc	185
collagen	182
hif	179
longitudinal	179
nfkb	178
lmm	178
stz	176
gfr	174
pubmed	170
ua	170
epigenetics	169
japan	165
bioinf	164
power	163
p38	163
cea	163
gender	162
lead	160
rage	159
cadmium	158
dna-damage	157
ref	154
genomics	148
vitamin-d	148
stata	147
ctgf	144
network	143
liver	138
book	137
screening	137
rt	136
company	135
diet	134
seq	132
phosphorylation	130
protein	128
go	125
systems-biology	124
pathway	124
cell-cycle	123
esrd	123
kinase	122
no	121
mt	120
pkc	120
lipid	118
s6k	115
creatinine	115
statin	114
senescence	106
proliferation	106
podocyte	105
mapk	104
regression	103
fish	103
gfr-formula	102
case-control	102
cad	102
pd	102
imputation	101
multiplicity	100
imaging	99
insulin	98
observational	98
rx	97
plasmid	97
cloning	96
p21	95
pediatric	95
methylation	95
recurrent	94
sirt	93
blood	92
betel	91
tnf	90
nhanes	90
nox	90
chf	90
website	89
pparg	89
toxicology	88
phenotype	88
diagnosis	87
cytokine	87
src	87
anemia	87
immunity	86
stat	86
lr	86
uti	85
at1	84
china	83
epo	82
ebm	81
oat	81
ca	81
nonp	81
p	81
cachexia	80
hapmap	80
hypertrophy	80
environment	80
primer	78
gout	78
qms	77
review	75
autophagy	73
ko	73
gene-therapy	73
missing	73
promoter	73
lpd	72
gene-list	72
surrogate	72
eqtl	72
stone	72
p-value	71
mv	71
signaling	71
ace	71
salt	70
egf	69
phd	69
cox2	68
mgo	66
tin	66
uncertainty	66
normalization	65
mirna-target	65
chinese	65
gpcr	64
association	64
enddysf	63
causation	63
glycemia	63
yeast	63
foxo	63
2dge	63
acid-base	63
jnk	62
smoking	62
simulation	62
me	62
uuo	61
pla2	61
avf	61
confounding	61
ptm	61
hts	61
melamine	60
pe	60
infection	60
change	60
sas	60
outcome	60
cost	59
oral	59
eif	59
shc	59
ifn	59
crp	58
mmp	58
llcpk1	58
alcohol	58
fluorescence	57
nrk49f	57
robust	57
model-selection	57
pls	57
achr	57
urate-transporter	57
pai1	57
calibration	56
semantic	56
pdgf	56
hsp	56
aceiarb	56
hk2	56
oglcnac	55
goldstd	55
ratio	55
competing-risk	55
function	54
iron	54
stem-cell	54
estrogen	54
workflow	54
bone	54
ckd-progression	54
k	53
renoprotection	53
dipstick	53
std	53
dimerization	52
rho	52
qc	52
ace2	52
ncrna	52
histone	52
cyclin-d1	51
vegf	51
fgf	51
pth	51
epidemiology	51
normoalbuminuria	51
atm	51
lod	51
graph	50
risk-ratio	50
reasoning	50
arsenic	50
matlab	50
mercury	50
tf	49
gene-environment	49
hsc	49
ab	49
antibiotics	49
4ebp	49
epistasis	49
adpkd	49
ngal	48
ffpe	48
breakpoint	48
klotho	48
nrk52e	48
ukm	48
core-curriculum	48
pld	48
pooling	47
spot-urine	47
mesangial	47
joint-model	47
endothelium	47
hdac	46
translation	46
dub	46
aspirin	46
hgf	46
p27	46
il6	46
cystatin	46
fdr	46
ecm	46
protein-microarray	46
semip	45
wnt	45
writing	45
metal	45
fgf23	45
prevention	45
rapamycin	45
aldosterone	45
ras	44
biosensor	44
interaction	44
variability	44
ancova	44
ccb	44
diuretics	44
na	43
enos	43
klf	43
design	43
cnv	43
sle	43
bia	43
good	42
bmi	42
sumo	42
icu	42
roc	42
agreement	42
ampk	42
stroke	42
er-stress	41
tgfbr	41
risk	40
fuzzy	40
wga	40
hyperfiltration	40
gene-targeting	40
alignment	40
qtl	40
dbdb	40
igf	40
asia	39
dry-bw	39
urinalysis	39
hepatocyte	39
protein-complex	38
myc	38
tea	38
ap1	38
igan	38
angiogenesis	38
sage	38
adh	37
bh4	37
rvh	37
haplotype	37
hematuria	37
emr	37
antisense	37
fabp	37
mtorc1	37
propensity	37
tlr	37
animal	37
omics	36
rsk	36
adenosine	36
megalin	36
web20	36
inflammasome	36
catenin	36
cardiorenal	36
cre	35
calcification	35
adduct	35
chemogenomics	35
annotation	35
threshold	35
candidate-gene	35
gsk	35
proteasome	35
reverse-epidemiology	35
s100b	35
subgroup	35
msm	34
cross-species	34
exercise	34
coffee	34
pathology	34
sepsis	34
effect-size	34
nephrotoxicity	34
attrition	34
rca	33
ns	33
sp1	33
fibronectin	33
zeb	33
sarcopenia	33
snx	33
cage	33
ecology	33
integrin	33
il1	32
text-mining	32
end-point	32
addgene	32
orbitrap	32
affy	32
zfn	32
browser	32
risk-difference	31
macrophage	31
hospitalization	31
emsa	31
fc	31
transactivation	31
gllamm	31
set	31
abp	31
heritability	31
blast	31
frailty	31
rtk	31
family	31
vsmc	31
steroid	31
knockout	30
notch	30
silac	30
staging	30
transporter	30
bmp	30
mw	30
membrane-protein	30
carcinogen	30
creb	30
irs1	30
ai	29
validation	29
reporter	29
s100	29
perindopril	29
nutrient	29
grn	29
ub-ligase	29
3	29
extraction	29
nicotinic	29
virus	29
pka	29
et	29
geo	28
acetylation	28
time-dependent	28
scaling	28
gee	28
mutagenesis	28
race	28
human	27
mendelian	27
pdz	27
ce	27
cari	27
spla2	27
ndrd	27
thp	27
ck2	27
thesis	27
classification	27
mtorc2	27
peptide-microarray	26
gsh	26
renin	26
metagenomics	26
hba1c	26
muscarinic	26
agt	26